Annual CFI
-$5.90B$4.12B-232.20%
Summary
- Current Value
- As of today, GSK annual cash from investing is -$5.90B, down -232.20% on
- Historical Performance
- GSK annual cash from investing is up +45.81% over the past 3 years, down -319.58% over the past 5 years
- All-Time High Comparison
- GSK annual cash from investing is currently -165.05% below its historical high of $9.06B set on
- 3-Year Low Comparison
- GSK annual cash from investing is +45.81% above its 3-year low of -$10.88B reached on an earlier date
- Sector Comparison
- GSK annual cash from investing is higher than 0.71% of companies in Healthcare sector
Cash From Investing Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Investing | -$5.90B | -232.2% | +45.8% | -319.6% | -91.7% | |
| Quarterly Cash From Investing | -$1.18B | -42.8% | +11.6% | -330.2% | -168.4% | |
| TTM Cash From Investing | -$8.30B | -70.5% | -12.0% | -653.8% | -842.3% | |
| Price | $50.27 | +26.0% | +44.6% | +20.8% | +17.6% | |
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Annual Cash From Financing | -$3.96B | +24.4% | -293.4% | +66.7% | +46.5% | |
| Annual CAPEX | $3.93B | +3.2% | +41.4% | +37.0% | +55.9% | |
| Annual Free Cash Flow | $5.69B | +43.2% | +5.8% | -17.9% | -18.3% | |
| Annual Total Assets | $82.21B | +10.4% | +13.6% | -25.2% | +24.3% |
Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$1.77B | -232.2% | |
| 5Y | $2.69B | N/A | -319.6% |
| All | $9.06B | -165.1% |
Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$10.88B | N/A | +45.8% |
| 5Y | -$10.88B | +45.8% | |
| All | -$14.62B | +59.7% |
Cash From Investing History
FAQ
- What is the current annual cash from investing of GSK?
- As of today, GSK annual cash from investing is -$5.90B
- What is 1-year change in GSK annual cash from investing?
- GSK annual cash from investing is down -232.20% year-over-year
- What is 3-year change in GSK annual cash from investing?
- GSK annual cash from investing is up +45.81% over the past 3 years
- How far is GSK annual cash from investing from its all-time high?
- GSK annual cash from investing is currently -165.05% below its historical high of $9.06B set on December 31, 2015
- How does GSK annual cash from investing rank versus sector peers?
- GSK annual cash from investing is higher than 0.71% of companies in Healthcare sector
- When is GSK next annual earnings release?
- As of today, the next annual earnings release for GSK has not been scheduled
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Quarterly CFI
-$1.18B$607.72M+34.07%
Summary
- Current Value
- As of today, GSK quarterly cash from investing is -$1.18B, up +34.07% on
- Historical Performance
- GSK quarterly cash from investing is down -42.80% year-over-year, up +11.63% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from investing is currently -111.03% below its historical high of $10.66B set on
- 3-Year Low Comparison
- GSK quarterly cash from investing is +63.05% above its 3-year low of -$3.18B reached on
- Sector Comparison
- GSK quarterly cash from investing is higher than 1.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Investing | -$1.18B | +34.1% | -42.8% | +11.6% | -330.2% | |
| Annual Cash From Investing | -$5.90B | – | -232.2% | +45.8% | -319.6% | |
| TTM Cash From Investing | -$8.30B | -4.4% | -70.5% | -12.0% | -653.8% | |
| Price | $50.27 | -2.5% | +26.0% | +44.6% | +20.8% | |
| Quarterly Cash From Operations | $3.39B | +128.2% | +37.4% | +152.8% | +151.0% | |
| Quarterly Cash From Financing | -$2.54B | -1209.8% | +8.4% | -678.3% | -6.1% | |
| Quarterly CAPEX | $874.46M | +46.5% | +5.1% | +29.9% | +12.8% | |
| Quarterly Free Cash Flow | $2.51B | +183.3% | +53.9% | +277.1% | +338.0% | |
| Quarterly Total Assets | $81.94B | -1.2% | +0.9% | +8.4% | -23.0% |
Quarterly Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$823.69M | N/A | -42.8% |
| 3Y | $924.65M | -227.2% | |
| 5Y | $924.65M | -227.2% | |
| All | $10.66B | -111.0% |
Quarterly Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$3.18B | +63.0% | |
| 3Y | -$3.18B | +63.0% | |
| 5Y | -$5.00B | +76.5% | |
| All | -$13.29B | +91.2% |
Quarterly Cash From Investing History
FAQ
- What is the current quarterly cash from investing of GSK?
- As of today, GSK quarterly cash from investing is -$1.18B
- What is GSK quarterly cash from investing most recent change?
- GSK quarterly cash from investing was up +34.07% on June 30, 2026
- What is 1-year change in GSK quarterly cash from investing?
- GSK quarterly cash from investing is down -42.80% year-over-year
- How far is GSK quarterly cash from investing from its all-time high?
- GSK quarterly cash from investing is currently -111.03% below its historical high of $10.66B set on March 31, 2015
- How does GSK quarterly cash from investing rank versus sector peers?
- GSK quarterly cash from investing is higher than 1.62% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TTM CFI
-$8.30B$352.53M-4.44%
Summary
- Current Value
- As of today, GSK TTM cash from investing is -$8.30B, down -4.44% on
- Historical Performance
- GSK TTM cash from investing is down -70.49% year-over-year, down -12.04% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from investing is currently -188.92% below its historical high of $9.33B set on
- 3-Year Low Comparison
- GSK TTM cash from investing is at its 3-year low
- Sector Comparison
- GSK TTM cash from investing is higher than 0.95% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Investing | -$8.30B | -4.4% | -70.5% | -12.0% | -653.8% | |
| Annual Cash From Investing | -$5.90B | – | -232.2% | +45.8% | -319.6% | |
| Quarterly Cash From Investing | -$1.18B | +34.1% | -42.8% | +11.6% | -330.2% | |
| Price | $50.27 | -2.5% | +26.0% | +44.6% | +20.8% | |
| TTM Cash From Operations | $10.64B | +9.5% | +12.7% | +128.9% | +44.9% | |
| TTM Cash From Financing | -$2.93B | +7.4% | +25.2% | -2.1% | +75.6% | |
| TTM CAPEX | $4.02B | +1.1% | +1.3% | +46.9% | +26.0% | |
| TTM Free Cash Flow | $6.62B | +15.3% | +21.0% | +246.3% | +59.5% | |
| Quarterly Total Assets | $81.94B | -1.2% | +0.9% | +8.4% | -23.0% |
TTM Cash From Investing Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$4.87B | N/A | -70.5% |
| 3Y | $292.30M | -2938.2% | |
| 5Y | $292.30M | -2938.2% | |
| All | $9.33B | -188.9% |
TTM Cash From Investing Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$8.30B | at low | |
| 3Y | -$8.30B | at low | |
| 5Y | -$10.88B | +23.7% | |
| All | -$19.30B | +57.0% |
TTM Cash From Investing History
FAQ
- What is the current TTM cash from investing of GSK?
- As of today, GSK TTM cash from investing is -$8.30B
- What is GSK TTM cash from investing most recent change?
- GSK TTM cash from investing was down -4.44% on June 30, 2026
- What is 1-year change in GSK TTM cash from investing?
- GSK TTM cash from investing is down -70.49% year-over-year
- How far is GSK TTM cash from investing from its all-time high?
- GSK TTM cash from investing is currently -188.92% below its historical high of $9.33B set on March 31, 2015
- How does GSK TTM cash from investing rank versus sector peers?
- GSK TTM cash from investing is higher than 0.95% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk